- Home
- MANU vs APGE Comparison
MANU vs APGE Comparison
Compare MANU & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MANU
- APGE
- Stock Information
- Founded
- MANU 1878
- APGE 2022
- Country
- MANU United Kingdom
- APGE United States
- Employees
- MANU N/A
- APGE N/A
- Industry
- MANU Services-Misc. Amusement & Recreation
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MANU Consumer Discretionary
- APGE Health Care
- Exchange
- MANU Nasdaq
- APGE Nasdaq
- Market Cap
- MANU 2.2B
- APGE 2.1B
- IPO Year
- MANU 2012
- APGE 2023
- Fundamental
- Price
- MANU $14.31
- APGE $37.29
- Analyst Decision
- MANU Buy
- APGE Strong Buy
- Analyst Count
- MANU 2
- APGE 4
- Target Price
- MANU $20.75
- APGE $91.33
- AVG Volume (30 Days)
- MANU 164.0K
- APGE 573.5K
- Earning Date
- MANU 02-19-2025
- APGE 05-20-2025
- Dividend Yield
- MANU N/A
- APGE N/A
- EPS Growth
- MANU N/A
- APGE N/A
- EPS
- MANU N/A
- APGE N/A
- Revenue
- MANU $777,029,683.00
- APGE N/A
- Revenue This Year
- MANU $2.44
- APGE N/A
- Revenue Next Year
- MANU $3.82
- APGE $743.14
- P/E Ratio
- MANU N/A
- APGE N/A
- Revenue Growth
- MANU N/A
- APGE N/A
- 52 Week Low
- MANU $12.05
- APGE $26.20
- 52 Week High
- MANU $18.42
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- MANU 59.90
- APGE 52.37
- Support Level
- MANU $14.17
- APGE $34.38
- Resistance Level
- MANU $14.60
- APGE $41.05
- Average True Range (ATR)
- MANU 0.32
- APGE 2.23
- MACD
- MANU 0.06
- APGE 0.10
- Stochastic Oscillator
- MANU 71.29
- APGE 51.48
About MANU Manchester United Ltd.
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, and sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which the majority of the revenue is generated including Commercial, Broadcasting, and Matchday.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.